- JAMJOOMPHARMA

Saudi Stock Exchange (Kingdom of Saudi Arabia)
167.2 Last Update 21/10/2024 21:31 KSA
lblNavigate
× lblWarning! {{companyMessage}}

Quotes

  • :168.2
  • :166.2
  • ('000):70,000
  • (SAR '000):11,704,000
  • :0


  • 49,387
  • :0
  • :
  • 52-W L52-W H
    167.2
    102.4202.4
  • 19.66%
  • 58.79%


  • 1,763

  • (SAR):

    8,274,268.6
  • (SAR):44,152,022
  • :0.19
  • Performance Comparison

At a Glance

Activities

Jamjoom Pharmaceuticals Factory is a Saudi joint stock company specialized in developing, manufacturing, marketing and selling generic pharmaceutical products, cosmetics, and healthcare products to consumers. Founded in 2000, the company quickly emerged as one of the leading pharmaceutical companies in the Middle East, Africa and CIS regions. Jamjoom Pharma is ranked among the top 5 pharmaceutical companies globally (IMS) and occupies third place in the total pharmaceutical market in Saudi Arabia (IQVIA). The company has received praise from Frost & Sullivan for its dominance in the pharmaceutical market in Saudi Arabia. In addition, Mr. Nour Sherif, Managing Director, was honored with the European Business Association (EBA) Manager of the Year Award for Innovative Business Strategies. Jamjoom Pharma operates modern manufacturing facilities managed by specialized teams. The company exports its products to more than 30 countries. The company is distinguished by the high quality of its products and its wide distribution network, making it one of the leading companies in the region.

Board of Directors:

  • Chairman:
    Mahmoud Y. S. Jamjoom
  • Vice-chairman:
    Ahmed Y. M. Jamjoom
  • CEO:
    Tarek Y. Hosni
  • Board Members:

    Ahmed Y. M. Jamjoom

    Alaa Y. M. Salah Jamjoom

    Faris I. A. Al-Ghannam

    Georges P. Schorderet

    Michel M. J. Le Bars

    Mohammed Y. M. Jamjoom

    Noor A. K. Sheriff

    Yousuf M. S. Jamjoom

  • Auditors:

    KPMG Professional Services

Senior Management

CFO

Anwer Mohiuddin

Global Manufacturing Officer

Mehmet A. Ozenler

Head of Legal Department

Ammar A. Al-Attas

HR Director

Mazen Al-Serehi

Commercial Director

Wagih M. Al-Bokl

Recent Profit / Loss Announcements

Announced On Period As Of Net Profit (SAR Mil) Growth (%)
27/10/2024 9-Month 30/09/2024 305 22.99
06/08/2024 6-Month 30/06/2024 210 23
09/05/2024 3-Month 31/03/2024 103 22
25/03/2024 12-Month 31/12/2023 292 70.68
07/11/2023 9-Month 30/09/2023 248 77.63
Contact Details

Related GCC Companies (Health Care)

Market Cap
US$ Mil		 Last Price
Local Cry		 Price Change (%)
1 Day		 Price Change (%)
1 Year		 P/E TTM P/B MRQ Dividend Yield (%) Beta ROA (%) ROE (%)
SULAIMANALHABIB 27,049.75 291.8 0.62 0 46.65 0 0 0 0 0
MOUWASAT 5,218.07 98.1 0.2 0 29.45 0 0 0.81 0 0
NAHDI 4,469.21 130 0.77 0 19.41 0 0 0 0 0
DALLAHHEALTH 4,113.05 160.4 1.51 0 34.79 0 0 0.93 0 0
FAKEEHCARE 3,616.94 59.5 1.7 0 49.56 0 0 0 0 0
JAMJOOMPHARMA 3,130.31 167.2 -0.36 0 35.42 0 0 0 0 0
CARE 2,270.98 184 -3.16 0 29.63 0 0 0.85 0 0
SAUDIGERMANHEALTH 1,793.05 73 -0.14 0 33.16 0 0 0.79 0 0
SPIMACO 989.78 31.8 2.74 0 -904.97 1.41 0 0.91 8.47 15.11
AVALONPHARMA 704.63 135.2 2.26 0 33.28 0 0 0 0 0
MIDAN 528.86 796 6.98 0 28.42 1.39 0 0 12.06 17.87
EQUIPMENTHOUSE 417.34 52.3 0.19 0 32.84 0 0 0 0 0
AYYAN 403.37 15 -0.27 0 -6.52 0 0 0.81 0 0
MCGS 352.6 4.55 -1.11 -27.12 19.71 0.13 5.86 0.98 4.88 6.49
GMPC 351.95 1.85 -2.12 -27.2 0 0.98 3 -0.08 75.81 111.42
BURJEEL 342.87 2.42 4.76 0 0 0 0 0 0 0
JULPHAR 284.74 0.93 0 4.35 -19.06 0.45 5.27 0.2 4.09 0
ATC.KSE 214.09 435 0 13.4 7.3 1.32 1.82 -0.01 2.93 12.88
RPM 195.98 3.6 -1.1 0 0 0 0 0 0 0
QGMD 48.31 1.54 0.19 -41.73 0 0 0 0.76 0 0
logo

Financial Information Co.

GCC Markets

Mutual Funds

News

Investment Tools

Sector News

Screeners

Indices & Commodities

Downloads

Copyright ©2001 - 2025, Financial Information Co. All Rights Reserved.

Terms of Services | Privacy Policy | Advertise with us | Contact Us | Sitemap